Organic Letters
Letter
the [3 + 2]-cycloaddition to obtain bicyclic pyrazolidinones
34−37 with high enantiomeric excesses (Table 3). The
azomethine imine auxiliary was sequentially removed to yield
monocyclic pyrazolidinones without loss of optical activity
(38−41).
REFERENCES
■
(1) For selected reviews, see: (a) Synthetic Applications of 1,3-Dipolar
Cycloaddition Chemistry Toward Heterocycles and Natural Products;
Padwa, A., Pearson, W. H., Eds.; Wiley: Hoboken, NJ, 2002.
(b) Gothelf, K. V.; Jørgensen, K. A. Chem. Rev. 1998, 98, 863.
(2) Dorn, H.; Otto, A. Angew. Chem., Int. Ed. Engl. 1968, 7, 214.
(3) For a review on 1,3-dipolar cycloadditions of azomethine imines,
see: Najera, C.; Sansano, J. M.; Yus, M. Org. Biomol. Chem. 2015, 13,
8596.
Table 3. [3 + 2]-Cycloaddition with Optically Active
Azomethine Imines and C−N Cleavage to Remove
a
Auxiliary
(4) See Supporting Information for recent examples of azomethine
imine cycloadditions.
(5) Recent [3 + 2] cycloadditions with azomethine imine and copper
acetylides: (a) Shintani, R.; Fu, G. C. J. Am. Chem. Soc. 2003, 125,
10778. (b) Imaizumi, T.; Yamashita, Y.; Kobayashi, S. J. Am. Chem.
Soc. 2012, 134, 20049. (c) Hashimoto, T.; Takiguchi, Y.; Maruoka, K.
J. Am. Chem. Soc. 2013, 135, 11473. (d) Keller, M.; Sido, A. S. S.; Pale,
P.; Sommer, J. Chem. - Eur. J. 2009, 15, 2810.
(6) Recent [3 + 2] cycloadditions with azomethine imines and
alkynyl ketones: (a) Hori, M.; Sakakura, A.; Ishihara, K. J. Am. Chem.
Soc. 2014, 136, 13198. (b) Arai, T.; Ogino, Y.; Sato, T. Chem.
Commun. 2013, 49, 7776.
(7) Hashimoto, T.; Maeda, Y.; Omote, M.; Nakatsu, H.; Maruoka, K.
J. Am. Chem. Soc. 2010, 132, 4076.
b
c
d
compd
R1
R2
Ph
yield (%)
dr
ee (%)
(−)-34
(−)-35
(+)-36
(+)-37
(−)-38
(−)-39
(+)-40
(+)-41
Ph
Ph
84
92
86
83
95
86
85
79:21:−:−
83:17:−:−
76:24:−:−
85:15:−:−
91:9
nd
nd
nd
nd
n-C4H9
Ph
4-BrC6H4
4-BrC6H4
Ph
n-C4H9
Ph
(8) Hesping, L.; Biswas, A.; Daniliuc, C. G.; Muck-Lichtenfeld, C.;
Studer, A. Chem. Sci. 2015, 6, 1252.
f
>99
f
Ph
n-C4H9
Ph
87:13
99
(9) Other tetrahydroisoquinoline−pyrazolidinone products from N-
iminoisoquinoline ylide cycloadditions: (a) Li, B.-S.; Wang, Y.; Jin, Z.;
Chi, Y. R. Chem. Sci. 2015, 6, 6008. (b) Gao, Z.-H.; Chen, X.-Y.;
Cheng, J.-T.; Liao, W.-L.; Ye, S. Chem. Commun. 2015, 51, 9328.
(10) Reviews on ynolates: (a) Shindo, M. Chem. Soc. Rev. 1998, 27,
367. (b) Shindo, M. Synthesis 2003, 15, 2275. (c) Shindo, M.
Tetrahedron 2007, 63, 10.
g
4-BrC6H4
4-BrC6H4
90:10
94
e
g
n-C4H9
78
88:12
95
a
b
c
determined by 1H NMR. ee determined by HPLC. nd = not
e
determined. 88% yield of a 8.8:1 mixture with the corresponding
pyrazolone. Azomethine imine ee >99%. Azomethine imine ee 92%.
f
g
(11) Cycloadditions of ynolates: (a) Schollkopf, U.; Hoppe, I. Angew.
̈
Chem., Int. Ed. Engl. 1975, 14, 765. (b) Kai, H.; Iwamoto, K.; Chatani,
N.; Murai, S. J. Am. Chem. Soc. 1996, 118, 7634. (c) Iwamoto, K.;
Kojima, M.; Chatani, N.; Murai, S. J. Org. Chem. 2001, 66, 169.
(d) Shindo, M.; Itoh, K.; Tsuchiya, C.; Shishido, K. Org. Lett. 2002, 4,
3119. (e) Shindo, M.; Yoshimura, Y.; Hayashi, M.; Soejima, H.;
Yoshikawa, T.; Matsumoto, K.; Shishido, K. Org. Lett. 2007, 9, 1963.
(f) Austin, W. F.; Zhang, Y.; Danheiser, R. L. Org. Lett. 2005, 7, 3905.
(12) For analysis of nitrogen heterocycles in U.S. FDA approved
pharmaceuticals, see: Vitaku, E.; Smith, D. T.; Njardarson, J. T. J. Med.
Chem. 2014, 57, 10257.
In summary, we developed a novel [3 + 2]-cycloaddition of
ynolates and azomethine imines to synthesize bicyclic
pyrazolidinones in high yields and diastereoselectivities. At
this time, it is not clear if the reaction is stepwise or
concerted.17 Nonetheless, this is the first example in which
the azomethine imine acts as a chiral auxiliary to control the
cycloaddition. We have defined conditions for its removal to
yield optically active monocyclic pyrazolidinones.
(13) For examples of biologically active dinitrogen pyrazolidinones,
(14) Gould, E.; Lebl, T.; Slawin, A. M. Z.; Reid, M.; Smith, A. D.
Tetrahedron 2010, 66, 8992.
(15) Ma, G.; Deng, J.; Sibi, M. P. Angew. Chem., Int. Ed. 2014, 53,
11818.
(16) (a) Julia, M.; Saint-Jalmes, V. P.; Verpeaux, J.-N. Synlett 1993,
1993, 233. (b) Sweis, R. F.; Schramm, M. P.; Kozmin, S. A. J. Am.
Chem. Soc. 2004, 126, 7442.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
X-ray crystal data for (−)-36 (CIF)
Experimental methods, characterization data, and NMR
(17) Roca-Lop
2015, 80, 4076.
́
ez, D.; Polo, V.; Tejero, T.; Merino, P. J. Org. Chem.
t
(18) Commercially available BuOOH (∼5.5 M solution in decane)
t
AUTHOR INFORMATION
Corresponding Author
was used. For a detailed discussion of BuOOH and for the effects of
■
(19) Examples where part of the azomethine imine is removed: (a)
Reference 6a. (b) Jungheim, L. N.; Sigmund, S. K. J. Org. Chem. 1987,
52, 4007.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We would like to thank Dr. M. Kevin Brown (Indiana
University) for the suggestion of utilizing ethynyltrimethyl-
silane. Financial support provided by the NIH (GM102403)
and the Welch Foundation (I-1612). X-ray crystallography
performed by Dr. V. Lynch (UT Austin).
D
Org. Lett. XXXX, XXX, XXX−XXX